Lexicon Pharmaceuticals Inc

NASDAQ:LXRX  
2.13
0.00 (0.00%)
3:40:44 PM EDT: $2.11 -0.02 (-0.94%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)401.99M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.05 Million
Adjusted EPS-$0.13
See more estimates
10-Day MA$2.19
50-Day MA$2.24
200-Day MA$2.32
See more pivots

Lexicon Pharmaceuticals Inc Stock, NASDAQ:LXRX

2445 Technology Forest Boulevard, 11th floor, The Woodlands, Texas 77381-1160
United States of America
Phone: +1.281.863.3000
Number of Employees: 87

Description

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.